Skip to content
NASDAQ · RETAIL-DRUG STORES AND PROPRIETARY STORES · SMALL CAP

111, Inc. YI

10 fiscal years on record · CNY · FY2025 reported · SEC filings only
CNY 12.6B
▼ 12.8% YoY
CNY -22.5M
CNY 114.7M
▼ 53.7% YoY
In brief

What this company does

111, Inc. provides hundreds of millions of consumers with access to pharmaceutical products and medical services through its online retail pharmacy network. Its online wholesale pharmacy, 1 Pharmacy, serves as a one-stop shop for pharmacies, clinics, and hospitals to source pharmaceutical products. As of December 31, 2025, the company had served more than 500,000 pharmacies, including small and medium-sized retail pharmacy chains, independent pharmacies, and in-house pharmacies within clinics and private hospitals, spanning 31 provinces in China. As of December 31, 2025, its technology and IT team consisted of 144 employees. The company's founders launched 1 Medicine Marketplace in 2010, one of the first online retail pharmacies in China.

Written from the business description in 111, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 30 April 2026. Every sentence was checked against that document before publication.

Growth
CNY 12.6B
Revenue, FY2025 · full 10-year series below
Revenue CNY B Net income CNY B
FY2025 · Revenue 12.6 · Net income -0.0
5B10B2016201720182019202020212022202320242025
Compound annual growth
−2.4%
+8.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.9% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−0 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -0.0% · Net -0.2%
-20%-40%2016201720182019202020212022202320242025
ROE
FY2021 · ROE -674.7%
-200%-400%-600%2016201720182019202020212022202320242025

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow CNY M
FY2025 · FCF 114.7
100M200M-400M2016201720182019202020212022202320242025
Net buybacks CNY M Dividends CNY M
FY2021 · Dividends — · Net buybacks 3.0
4M8M201920202021

Total assetsCNY 2.2B
EquityCNY -702.2M
CashCNY 511.0M
Gross debtCNY 187.6M
Net debtCNY -323.3M
Current ratio1.09×

Equity was negative — liabilities exceeded assets. No ratio is shown.

The 10-year record
10 fiscal years
Every figure from documents filed with the SEC · CNY

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016
Revenue CNY B12.614.414.913.512.48.24.01.81.00.9
Operating income CNY B−0.00.0−0.4−0.4−0.6−0.5−0.5−0.4−0.3−0.4
EBITDA CNY B0.00.0−0.3−0.3−0.6−0.5−0.5−0.4−0.2−0.4
Income tax CNY B0.00.00.00.00.00.00.00.0··
Net income CNY B−0.0−0.0−0.4−0.4−0.6−0.5−0.5−0.4−0.2−0.4
Free cash flow CNY B0.10.2−0.5−0.1−0.8−0.1−0.5−0.4−0.2−0.4
EPS, diluted CNY −0.38−0.38−2.33−2.50−4.04−2.77−3.05−3.82−3.45−5.81
Dividend / sh CNY ··········
Payout %··········
ROE %····−674.7−82.4−50.2−274.7··
Shares out B·········0.07

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures · 2 divergences in 47 reconciliationsAUDITED

Reconciled in 8 of 19 fiscal years. 2 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 48 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures2 divergent
ActivityRetail-Drug Stores and Proprietary Stores
Listed onNASDAQ
Incorporated inoutside the United States — SEC code E9
Fiscal year endsDecember 31
Data on record since2015

Share this section

Download image